Transplant Diagnostics Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2028

$ PRICE - $ 3,000.00$ 8,900.00

Transplant Diagnostics Market by Application (Blood Profile, HLA, Pathogen Detection), by Technology (NGS, PCR, Sanger Sequencing), by Product (Instrument, Reagent, Software), by Type (Liver, Bone Marrow, Heart, Kidney), by End User (Hospital) – Global Forecast to 2028

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The Transplant Diagnostics Market is anticipated to grow at a rate of 7.04% during the forecast period 2021 to 2028 and is projected to grow at USD 672.50 million till 2028. Transplantation is one of the most preferred treatment options given to the patients suffering from chronic dialysis therapy. It is the most workable option in conditions associated with bone marrow, heart and liver. Due to the technological development, a number of transplant procedures are performed in the multispecialty hospitals due to the increasing funding offered by private collaborations and government.  In order to analyze the level of infection inside an organ, the diagnosis in transplants is performed at the end of donor and patient. There are a few restraints of the transplant diagnostics market such as high price of transplants, reimbursement policies, ethical and social problems connected to organ transplants and irregular insurance.  There is much improvement is diagnostic process crucially with companies dedicated to developing antibody monitoring, software, HLA typing technologies and instrument. It is regularly being utilized for diagnostics during transplantation around various body organs. The transplant diagnostics is essential to evaluate various aspects liked with a transplant while performing pre and post transplantation. One of the primary factors driving the growth of the transplant diagnostics market is the increase in the number of organ transplants performed around the world. The disparity between organ demand and availability, which is always greater than supply, accelerates the expansion of the transplant diagnostics market. The transplant diagnostics market is also influenced by an increased preference for preventative care testing, public awareness regarding organ donation and transplantation, and an increase in the incidences of infectious illnesses such as COVID-19. Furthermore, improvements to healthcare facilities, favourable government efforts, an increase in public-private funding for targeted research activities, improved healthcare infrastructure, and an increase in healthcare expenditure all have a beneficial impact on the transplant diagnostics industry. Furthermore, during the forecast period of 2021 to 2028, technological developments and an increase in the adoption of cross-matching and chimerism testing during pre- and post-transplantation would provide lucrative opportunities for transplant diagnostics market participants.


Transplant Diagnostics Market

MARKET SUMMARY
-
7.04%
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 7.04%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Transplant Diagnostics Market

  • This market report covers the forecasting of revenue growth at regional, country and global levels to provide an analysis of the recent industry tactics and opportunities in each of the sub-sectors during 2014 to 2024. In order to the in-detail study, this report has segmented the global transplant diagnostics market report according to by Application,by Technology, by product, by type.
  • The increased frequency of chronic diseases, growth in robot-assisted laboratory automation of diagnostic operations, and technical advancement in the field of human leukocyte antigen (HLA) typing are some of the important drivers driving the worldwide transplant diagnostics market.
  • Furthermore, rising public-private investment to develop innovative human leukocyte antigen (HLA) testing products, rising application of HLA typing products in clinical diagnostics, improving healthcare infrastructure in developing countries, continuous reduction in average cost of gene sequencing, and growing installation base of PCR and NGS instruments are all driving the global market forward.
Market Key Players
  • LXN Corporation
  • Horiba Medical
  • Alpha Laboratories
  • Cylex Inc
  • Otsuka Holdings Co Ltd
  • Laboratory Corporation of America Holdings
Growth

Transplant Diagnostics Market

Transplant diagnostics are performed for checking the compatibility between organ donor and recipient before or after transplant. The transplant diagnostics is anticipated to record a huge increase due to the rising occurrence of chronic illnesses, which result into failure of the organ. The market obtained the interest of several healthcare providers because of different advantages provided by such tests for the evaluation of the viability of the organ transplant process. Crucial technological developments have been recorded in transplant diagnostics for offering advanced diagnostic alternatives to manage organ transplant. In many developed countries, the market is in growing position as rising regions like Asia Pacific and LAMEA recorded several opportunities for transplant diagnostics. Increase in the count of organ transplant around the globe serves as the chief factors impelling the market growth. Growing transplantation, increasing awareness among people about organ donation and increasing preference towards precautionary care testing enhance the transplant diagnostic market growth.


North-America Got Significant Share

Transplant Diagnostics Market

North America among the top regions obtained the huge market revenue share in transplant diagnostics market due to the increasing adoption of advanced development, well-developed availability of capable experts, availability of capable professionals, preference towards diagnostic tools and huge healthcare expenses in the region.This analysis category provides details of the transplant diagnostics market by competitor. These details cover industry financials, potential, new market initiatives, production capacities, product launch, industry overview, revenue generated, industry strengths and weaknesses, global presence, production capacities and investment in research and development.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Transplant Diagnostics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • LXN Corporation
  • Horiba Medical
  • Alpha Laboratories
  • Cylex Inc
  • Otsuka Holdings Co Ltd
  • Laboratory Corporation of America Holdings
  • Randox Laboratories Ltd
  • Thermo Fisher Scientific Inc
  • TransMedics, Inc.
  • Medtronic
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • Zimmer Biomet
  • Pfizer Inc.
  • Preservation Solutions, Inc
  • Sanofi, Terumo Corporation
  • Stryker

Description

The Transplant Diagnostics Market is anticipated to grow at a rate of 7.04% during the forecast period 2021 to 2028 and is projected to grow at USD 672.50 million till 2028. Transplantation is one of the most preferred treatment options given to the patients suffering from chronic dialysis therapy. It is the most workable option in conditions associated with bone marrow, heart and liver. Due to the technological development, a number of transplant procedures are performed in the multispecialty hospitals due to the increasing funding offered by private collaborations and government.  In order to analyze the level of infection inside an organ, the diagnosis in transplants is performed at the end of donor and patient. There are a few restraints of the transplant diagnostics market such as high price of transplants, reimbursement policies, ethical and social problems connected to organ transplants and irregular insurance.  There is much improvement is diagnostic process crucially with companies dedicated to developing antibody monitoring, software, HLA typing technologies and instrument. It is regularly being utilized for diagnostics during transplantation around various body organs. The transplant diagnostics is essential to evaluate various aspects liked with a transplant while performing pre and post transplantation. One of the primary factors driving the growth of the transplant diagnostics market is the increase in the number of organ transplants performed around the world. The disparity between organ demand and availability, which is always greater than supply, accelerates the expansion of the transplant diagnostics market. The transplant diagnostics market is also influenced by an increased preference for preventative care testing, public awareness regarding organ donation and transplantation, and an increase in the incidences of infectious illnesses such as COVID-19. Furthermore, improvements to healthcare facilities, favourable government efforts, an increase in public-private funding for targeted research activities, improved healthcare infrastructure, and an increase in healthcare expenditure all have a beneficial impact on the transplant diagnostics industry. Furthermore, during the forecast period of 2021 to 2028, technological developments and an increase in the adoption of cross-matching and chimerism testing during pre- and post-transplantation would provide lucrative opportunities for transplant diagnostics market participants.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX